{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T21:10:03Z","timestamp":1790025003158,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["1RO1MH100999"],"award-info":[{"award-number":["1RO1MH100999"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["5P30-AI-50409"],"award-info":[{"award-number":["5P30-AI-50409"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"Department of Veterans Affairs","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.nbd.2016.02.007","type":"journal-article","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T16:47:17Z","timestamp":1454518037000},"page":"137-143","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"special_numbering":"PB","title":["The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model"],"prefix":"10.1016","volume":"92","author":[{"given":"Woldeab B.","family":"Haile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Gavegnano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sijia","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond F.","family":"Schinazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William R.","family":"Tyor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.nbd.2016.02.007_bb0005","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/00042560-199805010-00003","article-title":"SCID mice with HIV encephalitis develop behavioral abnormalities","volume":"18","author":"Avgeropoulos","year":"1998","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0010","first-page":"1","article-title":"Potential relationships between the presence of HIV, macrophages, and astrogliosis in SCID mice with HIV encephalitis","volume":"2","author":"Avgeropoulos","year":"1998","journal-title":"J. NeuroAIDS"},{"key":"10.1016\/j.nbd.2016.02.007_bb0015","doi-asserted-by":"crossref","first-page":"4202","DOI":"10.1182\/blood.V94.12.4202","article-title":"Constitutive activation of STATs upon in vivo human immunodeficiency virus infection","volume":"94","author":"Bovolenta","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.nbd.2016.02.007_bb0020","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/jcph.102","article-title":"Population pharmacokinetic analysis of orally-administered ruxolitinib (INCB018424 phosphate) in patients with primary myelofibrosis (PMF), post-polycythemia vera myelofibrosis (PPV-MF) or post-essential thrombocythemia myelofibrosis (PET MF)","volume":"53","author":"Chen","year":"2013","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0025","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.expneurol.2007.03.007","article-title":"Highly active antiretroviral therapy of cognitive dysfunction and neuronal abnormalities in SCID mice with HIV encephalitis","volume":"205","author":"Cook-Easterwood","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0030","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1002\/ana.20479","article-title":"Highly active antiretroviral therapy and human immunodeficiency virus encephalitis","volume":"57","author":"Cook","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0035","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/157016206777709500","article-title":"Mechanisms of HIV-1 neurotropism","volume":"4","author":"Dunfee","year":"2006","journal-title":"Curr. HIV Res."},{"key":"10.1016\/j.nbd.2016.02.007_bb0040","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3109\/13550280903131915","article-title":"Cliniconeuropathologic correlates of human immunodeficiency virus in the era of antiretroviral therapy","volume":"15","author":"Everall","year":"2009","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0045","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1089\/jir.2013.0072","article-title":"The recombinant vaccinia virus gene product, B18R, neutralizes interferon alpha and alleviates histopathological complications in an HIV encephalitis mouse model","volume":"34","author":"Fritz-French","year":"2014","journal-title":"J. Interf. Cytokine Res."},{"key":"10.1016\/j.nbd.2016.02.007_bb0050","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1128\/AAC.02012-12","article-title":"Cellular pharmacology and potency of HIV-1 nucleoside analogs in primary human macrophages","volume":"57","author":"Gavegnano","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.nbd.2016.02.007_bb0055","doi-asserted-by":"crossref","unstructured":"Gavegnano, C., et al., 2014. Ruxolitinib and tofacitinib are potent and selective inhibitors of HIV-1 replication and virus reactivation in vitro. Antimicrob. Agents Chemother. 014;58(4):1977\u201386.","DOI":"10.1128\/AAC.02496-13"},{"key":"10.1016\/j.nbd.2016.02.007_bb0060","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/ana.410380510","article-title":"Immunocytochemical quantitation of human immunodeficiency virus in the brain: correlations with dementia","volume":"38","author":"Glass","year":"1995","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0065","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1212\/WNL.0000000000000492","article-title":"Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline","volume":"82","author":"Grant","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.02.007_bb0070","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1098-1136(200005)30:3<253::AID-GLIA5>3.0.CO;2-O","article-title":"Activation of the JAK\/STAT pathway following transient focal cerebral ischemia: signaling through Jak1 and Stat3 in astrocytes","volume":"30","author":"Justicia","year":"2000","journal-title":"Glia"},{"key":"10.1016\/j.nbd.2016.02.007_bb0075","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s13365-013-0223-5","article-title":"Combined antiretroviral therapy reduces brain viral load and pathological features of HIV encephalitis in a mouse model","volume":"20","author":"Koneru","year":"2014","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0080","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neuroscience.2012.10.033","article-title":"Neurotoxins released from interferon-gamma-stimulated human astrocytes","volume":"229","author":"Lee","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.nbd.2016.02.007_bb0085","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.4049\/jimmunol.1200458","article-title":"Virologically suppressed HIV patients show activation of NK cells and persistent innate immune activation","volume":"189","author":"Lichtfuss","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0090","series-title":"Soluble CD14 and IL-1ra Levels Predict the Immune Activation Set Point in the Absence of Microbial Translocation in Primary HIV Infection. 20th Conference on Retroviruses and Opportunistic Infections, Atlanta, GA","author":"Chevalier","year":"2013"},{"key":"10.1016\/j.nbd.2016.02.007_bb0095","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s13365-011-0061-2","article-title":"Inhibition of interferon response by cystatin B: implication in HIV replication of macrophage reservoirs","volume":"18","author":"Rivera-Rivera","year":"2012","journal-title":"J. Neurovirol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0100","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1212\/WNL.0b013e3181d9ed09","article-title":"Neurocognitive effects of treatment interruption in stable HIV-positive patients in an observational cohort","volume":"74","author":"Robertson","year":"2010","journal-title":"Neurology"},{"key":"10.1016\/j.nbd.2016.02.007_bb0105","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1212\/CPJ.0000000000000117","article-title":"HIV-associated neurocognitive disorders: five new things","volume":"5","author":"Rumbaugh","year":"2015","journal-title":"Neurol. Clin. Pract."},{"issue":"16","key":"10.1016\/j.nbd.2016.02.007_bb0110","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1097\/QAD.0b013e3282f08c2f","article-title":"Cognitive dysfunction in HIV encephalitic SCID mice correlates with levels of Interferon-alpha in the brain","volume":"21","author":"Sas","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/j.nbd.2016.02.007_bb0115","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1523\/JNEUROSCI.5595-08.2009","article-title":"Interferon-alpha causes neuronal dysfunction in encephalitis","volume":"29","author":"Sas","year":"2009","journal-title":"J. Neurosci."},{"key":"10.1016\/j.nbd.2016.02.007_bb0120","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/QAD.0b013e3283437f9a","article-title":"HIV-1 infection and cognitive impairment in the cART era: a review","volume":"25","author":"Schouten","year":"2011","journal-title":"AIDS"},{"key":"10.1016\/j.nbd.2016.02.007_bb0125","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1097\/00042560-199510050-00004","article-title":"Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS","volume":"10","author":"Sippy","year":"1995","journal-title":"J. Acquir. Immune Defic. Syndr. Hum. Retrovirol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0130","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/arclin\/acu038.173","article-title":"B-85Genotype, CSF inflammation, and cognitive performance among African Americans and European Americans with HIV-infection","volume":"29","author":"Thames","year":"2014","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0135","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1002\/ana.1011","article-title":"Correlation between neurological progression and astrocyte apoptosis in HIV-associated dementia","volume":"49","author":"Thompson","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.nbd.2016.02.007_bb0140","doi-asserted-by":"crossref","first-page":"8658","DOI":"10.1073\/pnas.90.18.8658","article-title":"A model of human immunodeficiency virus encephalitis in scid mice","volume":"90","author":"Tyor","year":"1993","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.nbd.2016.02.007_bb0145","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1110557","article-title":"A double-blind, placebo-controlled trial of ruxolitinib for myelofibrosis","volume":"366","author":"Verstovsek","year":"2012","journal-title":"N. Engl. J. Med."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996116300286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996116300286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T18:42:06Z","timestamp":1600108926000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996116300286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":29,"alternative-id":["S0969996116300286"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2016.02.007","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726127212.793517951","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Janus kinase inhibitor ruxolitinib reduces HIV replication in human macrophages and ameliorates HIV encephalitis in a murine model","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2016.02.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}